JBM Healthcare Announces FY2026 Interim Results
KEY HIGHLIGHTS – Revenue increased 7.7% year-on-year to HK$429.6 million– Gross profit rose 23.2% to HK$253.6 million– Profit attributable to equity shareholders increased 20.0% to HK$115.0 million– Declared an interim dividend of HK9.75 cents per share– Ho Chai Kung and Po Chai Pills achieved steady growth supported by strong marketing and brand execution– Cross-border e-commerce […]